Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Certolizumab pegol (ATC-Code nach WHO: L04AB05)
openAOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen
Read the notice at vergabe-de ↗
Value
unstated
Published
19 Oct 2026
Deadline
31 Dec 2026, 22:59 GMT · 68d left · as published, verify on the notice
Type
opportunity
33600000 · Medical equipment, pharmaceuticals & personal careDEG01
Description
Siehe Kurzbeschreibung
Key facts
- Reference
- 130/2026-OH
- Procedure
- open
- Lots
- 1
- Contact
- Geschäftsbereich Unternehmenssicherheit, Zentrale Vergabestellevergabestelle@plus.aok.de+49 80010590-80071
- Regime
- publicSector
What a subscription adds to this notice
- The documents — every attachment, with its text extracted and searchable
- Qualification — the notice scored against your company profile
- Tracking and alerts — a pipeline for your bids, and the matching notices by email
- Calendar export — the deadline as a calendar file
- The API and MCP — the same record in your own tools and your AI assistant
Provenance
- Source
- vergabe-de
- Notice id
- 6b4eb660-3682-4044-96ac-8c58769d7741
- OCID
- ocds-mnwr74-0155ae3e-d893-438c-9701-b6d819d43aad
- First seen
- 22 Oct 2026
- Last updated
- 22 Oct 2026
Licence CC0 1.0 public domain dedication ↗
Source: Bekanntmachungsservice (oeffentlichevergabe.de), Beschaffungsamt des BMI — CC0 1.0.
View at source ↗
GET /api/v1/tenders/ababf9a1-12c9-43ed-ae6e-e67600550923The source notice is authoritative — verify deadlines and documents there before bidding.